Ally Bridge Group’s Curis CRIS Stock Holding History

Ally Bridge Group’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,068	Closed	-$455K	–	25
2022 Q4	$455K	Buy	2,068 +1,408	+213%	+$413K	0.44%	27
2022 Q3	$185K	Buy	+660	New	+$266K	0.12%	37

Other funds holding CRIS

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ally Bridge Group's CRIS Position: Q1 2023 in Review

Ally Bridge Group sold out of Curis (CRIS) in Q1 2023, closing a stake of 2,068 shares — an estimated $455K sold.

Ally Bridge Group first reported a position in CRIS in Q3 2022 and held it in 2 quarters. The position peaked at $455K in Q4 2022. 57 funds tracked by Wall St. Rank hold CRIS as of Q1 2023.

Ally Bridge Group reported no remaining Curis position as of Q1 2023 after selling out during the quarter.
Ally Bridge Group sold 2,068 Curis shares in Q1 2023, an estimated $455K.
Ally Bridge Group first reported a position in Curis in Q3 2022 and held it in 2 quarters.
Ally Bridge Group's Curis position peaked at $455K in Q4 2022.
57 funds tracked by Wall St. Rank held Curis as of Q1 2023.

Based on Ally Bridge Group's 13F filing for Q1 2023, filed 15 May 2023.